Beyond the Guidelines for CMV: Clinical Perspectives on Challenging Cases Post-Transplant: A Clinical Forum®

Target Audience
Infectious disease, transplantation, internal medicine, and nephrology clinicians

Program Overview
Cytomegalovirus (CMV) is a prevalent and potentially life-threatening viral infection in transplant recipients. CMV management in this high-risk population continues to evolve with updated guidelines and newer, less toxic antiviral therapy.

During this activity, faculty will discuss state-of-the-art strategies for preventing and treating CMV in transplant patients, sharing practical insights from challenging cases encountered in their clinical practice.

Educational Objectives
Upon completion of this activity, participants should be better able to: 

Apply treatment strategies for cytomegalovirus (CMV) infection in transplant recipients
Identify refractory or drug-resistant CMV in transplant recipients in the post-transplant setting
Integrate new antiviral therapies into management regimens for transplant recipients, including those who develop refractory or drug-resistant CMV